Although loss of Tfam at an early developmental stage leads to B cell lymphopenia, and thus the pool of B cells that may become malignant is reduced, the high penetrance of the model contrasted with the complete protection against lymphoma suggests that this is insufficient to explain the phenotype we observed. This evidence concerns the gene TFAM and lymphoma.